AS3MT
Arsenite methyltransferase
Also known as: AS3MT_HUMAN, CYT19
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HBK9
- Gene
- AS3MT
- Ensembl
- ENSG00000214435
- Chromosome
- 10
- Canonical length
- 375 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
AS3MT catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (AdoMet) to trivalent arsenical and may play a role in arsenic metabolism (Lin et al., 2002 [PubMed 11790780]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
375 residues, UniProt reviewed canonical sequence.
>Q9HBK9|AS3MT
1 MAALRDAEIQ KDVQTYYGQV LKRSADLQTN GCVTTARPVP KHIREALQNV HEEVALRYYG
61 CGLVIPEHLE NCWILDLGSG SGRDCYVLSQ LVGEKGHVTG IDMTKGQVEV AEKYLDYHME
121 KYGFQASNVT FIHGYIEKLG EAGIKNESHD IVVSNCVINL VPDKQQVLQE AYRVLKHGGE
181 LYFSDVYTSL ELPEEIRTHK VLWGECLGGA LYWKELAVLA QKIGFCPPRL VTANLITIQN
241 KELERVIGDC RFVSATFRLF KHSKTGPTKR CQVIYNGGIT GHEKELMFDA NFTFKEGEIV
301 EVDEETAAIL KNSRFAQDFL IRPIGEKLPT SGGCSALELK DIITDPFKLA EESDSMKSRC
361 VPDAAGGCCG TKKSCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AS3MT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 261 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 261 nTPM
- parathyroid gland: 53 nTPM
- liver: 44 nTPM
- heart muscle: 24 nTPM
- spleen: 16 nTPM
- kidney: 14 nTPM
Single-cell type
- choroid plexus epithelial cells: 23 nCPM
- ependymal cells: 16 nCPM
- brain excitatory neurons: 14 nCPM
- astrocytes: 14 nCPM
- brain inhibitory neurons: 14 nCPM
- other brain neurons: 13 nCPM
Immune cell
- NK-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 20 nTPM
- choroid plexus: 16 nTPM
- hypothalamus: 14 nTPM
- midbrain: 14 nTPM
- white matter: 14 nTPM
- pons: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.31
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.96
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Methyltransferase domain
- S-adenosyl-L-methionine-dependent methyltransferase superfamily
- Methyltransferase domain
- Arsenite methyltransferase-like
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AS3MT as an antibody target. Whether an autoantibody or antibody against AS3MT could matter depends on whether native AS3MT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AS3MT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AS3MT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...